Recombinant CALCRL (Erenumab Biosimilar) antibody

Catalog No. ABIN7538073

The Human Monoclonal anti-CALCRL (Erenumab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect CALCRL (Erenumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CALCRL (Erenumab Biosimilar) antibody (ABIN7538073)

Target: CALCRL (Erenumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CALCRL (Erenumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CALCRL (Erenumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Erenumab Biosimilar – Anti-CALCRL mAb - Research Grade

Characteristics: Antibody Type: IgG2-lambda

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG2 lambda

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CALCRL (Erenumab Biosimilar)

Target: CALCRL (Erenumab Biosimilar)

Target Type: Biosimilar

Background: Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.

CAS-No: 1582205-90-0